A single dose of MEDI-528, a monoclonal antibody against interleukin-9, is well tolerated in mild and moderate asthmatics in the phase II trial MI-CP-138 Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • O'Byrne, Paul
  • Boulet, Louis-Philippe
  • Cauvreau, Gail
  • Leon, Francisco
  • Sari, Suha
  • White, Barbara

publication date

  • October 1, 2007

published in